STAT5A and neoplasm: EGFR was thus activated in DFSP infiltrative periphery and DFSP-T, and EGFR signaling in DFSP tumor progression preferentially involved TOR and STAT5a/b downstream effectors, but not ERK in the MAPK pathway.